Molecular Epidemiology of Acute Myelogenous Leukemia
Ключові слова
Анотація
Опис
INFORMED CONSENTS FOR AML PATIENTS:
For this study, participant will be asked to complete a personal interview. During the interview, participant will be asked questions about participant's demographics (age, sex, etc.), any chemicals participant may have been exposed to, participant's medical history, family history of cancer, participant's diet, and participant's smoking and alcohol use histories. It should take around 50 minutes to complete the interview.
Participant will also have around 1 tablespoon of blood drawn for special tests. These tests will look for any biologic factors associated with AML.
The interview and the blood draw may be done during a regularly scheduled visit to M. D. Anderson, or may be scheduled at the time and place of participant's convenience.
Participant may be contacted at home by phone so that researchers can collect information about any changes in participant's health status.
This is an investigational study. Up to 1,200 participants will take part in this study.
INFORMED CONSENT FOR CONTROL SUBJECTS:
For this study, participant will be asked to complete a personal interview. During the interview, participant will be asked questions about participant's demographics (age, sex, etc.), any chemicals participant may have been exposed to, participant's medical history, family history of cancer, participant's diet, and participant's smoking and alcohol use histories. It should take around 50 minutes to complete the interview.
Participant will also have around 1 tablespoon of blood drawn for special tests. These tests will look for any biologic factors associated with AML. The interview and blood draw will be scheduled at the time and place of participant's convenience.
This is an investigational study. Up to 1,200 participants will take part in this study.
Дати
| Востаннє перевірено: | 12/31/2019 |
| Перший поданий: | 07/15/2007 |
| Орієнтовна реєстрація подана: | 07/16/2007 |
| Опубліковано вперше: | 07/17/2007 |
| Останнє оновлення надіслано: | 01/08/2020 |
| Останнє оновлення опубліковано: | 01/12/2020 |
| Фактична дата початку навчання: | 06/22/2003 |
| Розрахункова дата первинного завершення: | 09/29/2020 |
| Розрахункова дата завершення дослідження: | 09/29/2020 |
Стан або захворювання
Втручання / лікування
Behavioral: Interview
Фаза
Групи рук
| Рука | Втручання / лікування |
|---|---|
| Interview AML Patients & Healthy Controls | Behavioral: Interview Interview lasting approximately 50 minutes. |
Критерії прийнятності
| Вік, придатний для навчання | 18 Years До 18 Years |
| Стать, яка підходить для вивчення | All |
| Метод відбору проб | Non-Probability Sample |
| Приймає здорових добровольців | Так |
| Критерії | Inclusion Criteria: 1. A histologically confirmed diagnosis of AML (patients only) 2. Aged 18 or older 3. Resident of Texas 4. Willing and able to provide written informed consent and authorization 5. Willing to donate 10mL of blood and complete a personal interview Exclusion Criteria: 1. Under 18 years of age 2. History of invasive cancer, excluding non-melanoma skin cancer (controls only) |
Результат
Заходи первинного результату
1. Identify biologic and lifestyle factors that may increase a person's risk of developing acute myelogenous leukemia. [8 Years]
